Bio-active compounds and functional properties of pistachio hull: A review
Publication date: Available online 2 January 2020Source: Trends in Food Science &TechnologyAuthor(s): Edris Arjeh, Hamid-Reza Akhavan, Mohsen Barzegar, Ángel A. Carbonell-BarrachinaAbstractBackgroundPistachio (Pistacia vera L.) hull is the major part of pistachio by-product that has a high content of bio-active compounds (such as polyphenols, tocopherols, dietary fibers, essential oils, and unsaturated fatty acid) with antioxidant properties and health-promoting effects. However, it is considered as a waste and can lead to environmental problems.Scope and approachThis review presents the chemical composition, traditional and modern extraction methods and the reported functional effects of pistachio green hull, aiming to find potential uses for this valuable natural resource.Key findings and conclusions: Both in vivo and in vitro studies have demonstrated how pistachio extract acts as antioxidant, cytoprotective, and photoprotective and shows antibacterial, anti-inflammatory, anti-melanogenic, and anti-mutagenicity activities. Several studies evaluated the use of pistachio hull as a source of healthy and technological compounds that could be used in food and pharmaceutical industries to improve their products stability and nutritional characteristics. Further studies are needed to develop the application of this natural by-product.
Publication date: Available online 23 September 2020Source: Computers in Human BehaviorAuthor(s): Anat Shoshani, Shahar Braverman, Galya Meirow
Publication date: Available online 23 September 2020Source: Computers in Human BehaviorAuthor(s): Yan Wang, Haiyan Hao, Lisa Sundahl Platt
Publication date: Available online 21 September 2020Source: Computers in Human BehaviorAuthor(s): Chao-Ran Li, E. Zhang, Jing-Ti Han
Publication date: Available online 22 September 2020Source: Microbes and InfectionAuthor(s): Michael L. Jackson
PMID: 32960531 [PubMed - as supplied by publisher]
CORR Insights®: Is Growth-friendly Surgical Treatment Superior to One-stage Posterior Spinal Fusion in 9- to 11-year-old Children with Congenital Scoliosis? Clin Orthop Relat Res. 2020 Oct;478(10):2387-2389 Authors: Larson AN PMID: 32960530 [PubMed - as supplied by publisher]